Michal Tomczak, MD
Physician, Gastroenterology, Hepatology and Endoscopy
Dr. Michal Tomczak, an instructor at Harvard Medical School and a physician affiliated with the BWH Center for Crohn’s and Colitis, is a clinician who uses his background in IBD to work with patients and guide them to the most effective treatment possible.
Dr. Tomczak’s interests include cutting-edge medications for Crohn’s disease and colitis, new tools that will predict a person’s response to therapy, and the role that factors like diet may play in IBD.
As a researcher, Dr. Tomczak helped develop an experimental version of IBD in mice. Having a “mouse model” of IBD will accelerate research and increase the chances of finding effective treatments. Dr. Tomczak’s work has been supported by the National Institutes of Health and the Crohn’s and Colitis Foundation of America. His findings have been published in Nature, the prestigious science journal, and in other peer-reviewed publications.
Dr. Tomczak graduated from the Poznan University of Medical Sciences in Poland and trained as a resident at St. Elizabeth’s Medical Center in Boston. Following his residency, he was a clinical and research fellow at Brigham and Women’s Hospital.